書馨卡幫你省薪 2024個(gè)人購書報(bào)告 2024中圖網(wǎng)年度報(bào)告
歡迎光臨中圖網(wǎng) 請(qǐng) | 注冊(cè)

測(cè)量健康效用以用于成本效用分析

作者:王沛著
出版社:復(fù)旦大學(xué)出版社出版時(shí)間:2020-11-01
開本: 24cm 頁數(shù): 117頁
中 圖 價(jià):¥29.6(7.8折) 定價(jià)  ¥38.0 登錄后可看到會(huì)員價(jià)
加入購物車 收藏
運(yùn)費(fèi)6元,滿39元免運(yùn)費(fèi)
?新疆、西藏除外
本類五星書更多>

測(cè)量健康效用以用于成本效用分析 版權(quán)信息

測(cè)量健康效用以用于成本效用分析 內(nèi)容簡(jiǎn)介

Focusing on the assessment of health utility, the core component ofquality adjusted life years (QALYs) calculation, the author brieflycompares the utility values between the people in China and ChineseSingaporeans, as well as the values between the general populationand the people with diabetes, revealing how and why the valuesdiffer between them. The author also explicitly describes in thisbook how to establish scoring functions to yield utility values; andhow to compare different utility values, with the intention to gener-ate new knowledge on measuring health utility and provide healthservice researchers with useful tools and guidance for obtaining the values.

測(cè)量健康效用以用于成本效用分析 目錄

Chapter 1 Introduction 1.1 How to define health states 1 2How to measure HSU values 1.2.1 The direct method 1.2.2 The indirect method 1.2.3 Mapping health profiles to health-state utilities 1.3 Whose health-state utilities should be used 1.3.1 General population health-state utilities 1.3.2 Patient health-state utilities 1.4 Research objectives 1.5 Summary of studies Chapter 2 Do Chinese Have Similar Health-State Preferences? A Comparison of the People in China and Chinese Singaporeans 2.1 Introduction 2.2 Methods 2.2.1 Sampling and recruitment 2.2.2 Procedures 2.2.3 EQ-VT 2.2.4 Health states valued 2.2.5 Data analysis 2.3 Results 2.4 Discussion Chapter 3 The Impact of Diabetes on Health-State Utilities 3.1 Introduction 3.2 Methods 3.2.1 Study participants 3.2.2 Survey procedures 3.2.3 Health states valued 3.2.4 Data analysis 3.3 Results 3.4 Discussion Chapter 4 Valuation of EQ-gD-3L Health States in Singapore 4.1 Introduction 4.2 Methods 4.2.1 Sampling and recruitment 4.2.2 The valuation interview 4.2.3 The health states 4.3 Statistical analysis 4.3.1 Calculation of TTO values 4.3.2 Modeling of TTO values 4.3.3 Evaluation of model performance 4.4 Results 4.4.1 Respondents' characteristics 4.4.2 Distribution of TTO values 4.4.3 Modeling analysis 4.5 Discussion Chapter 5 Predicting Preference-Based SF-6D36 Index Scores from the SF-8 Health Survey 5.1 Introduction 5.2 Methods 5.2.1 SF 5.2.2 SF-6D 5.2.3 Data 5.2.4 Model construction 5.2.5 Model estimation and evaluation 5.3 Results 5.3.1 Individual-level prediction 5.3.2 Group-level prediction 5.4 Discussion Chapter 6 Preference-Based SF-6D Scores Derived from the SF-36 and SF-12 Have Different Discriminative Power in a Population Health Survey 6.1 Introduction 6.2 Methods 6.2.1 Data source 6.2.2 Instruments 6.2.3 Data analysis 6.3 Results 6.4 Discussion Chapter 7 Conclusions 7.1 Major findings 7.2 Contributions 7.3 Future studies Chart Index References
展開全部

測(cè)量健康效用以用于成本效用分析 作者簡(jiǎn)介

王沛,復(fù)旦大學(xué)公共衛(wèi)生學(xué)院副研究員、碩士生導(dǎo)師,Health and Quality of Lire Outcomes副主編,Pharmaco Economics-Onen編委,中國(guó)衛(wèi)生經(jīng)濟(jì)學(xué)會(huì)衛(wèi)生技術(shù)評(píng)價(jià)專委會(huì)委員,入選“2018年度上海市浦江人才計(jì)劃”。主要從事健康效用評(píng)估、健康相關(guān)生命質(zhì)量測(cè)量、健康量表的開發(fā)與驗(yàn)證、衛(wèi)生經(jīng)濟(jì)學(xué)評(píng)價(jià)等工作。

商品評(píng)論(0條)
暫無評(píng)論……
書友推薦
編輯推薦
返回頂部
中圖網(wǎng)
在線客服